Organogenesis Holdings Inc Stock Ownership - Who owns Organogenesis Holdings?

Insider buying vs selling

Have Organogenesis Holdings Inc insiders been buying or selling?
Gary S. GillheeneyPresident and CEO2024-04-0110,113$2.80
Lori FreedmanChief Admin. and Legal Officer2024-04-011,974$2.80
Antonio S. MontecalvoVice President Health Policy2024-04-011,752$2.80
Patrick BilboChief Operating Officer2024-04-012,497$2.80
Brian GrowChief Commercial Officer2024-04-011,977$2.80
Patrick BilboChief Operating Officer2024-03-28152,250$1.18
Lori FreedmanChief Admin. and Legal Officer2024-02-16646$3.48
Patrick BilboChief Operating Officer2024-02-16791$3.48
David FranciscoChief Financial Officer2024-02-16804$3.48
Gary S. GillheeneyPresident and CEO2024-02-163,788$3.48

1 of 3

ORGO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORGO insiders and whales buy or sell their stock.

ORGO Shareholders

What type of owners hold Organogenesis Holdings Inc stock?
Alan A. Ades97.03%128,631,721$330.58MInsider
Glenn H. Nussdorf96.73%128,243,003$329.58MInsider
Dennis Erani92.18%122,207,338$314.07MInsider
Erani Family Trust Dated 12 Albert89.68%118,896,054$305.56MInsider
Red Holdings LLC89.68%118,896,054$305.56MInsider
Erani 2012 Issue Trust Dated 12 Dennis89.68%118,896,054$305.56MInsider
2016 Organo 10year Grat Ua Gn44.84%59,448,027$152.78MInsider
Albert Erani44.51%59,007,134$151.65MInsider
David F. Burgstahler11.74%15,561,473$39.99MInsider
Morgan Stanley8.70%11,528,028$29.63MInstitution

1 of 3

ORGO vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORGO6.06%93.94%Net SellingNet Buying
EBS42.29%57.71%Net SellingNet Selling

Organogenesis Holdings Stock Ownership FAQ

Who owns Organogenesis Holdings?

Organogenesis Holdings (NASDAQ: ORGO) is owned by 42.62% institutional shareholders, 660.73% Organogenesis Holdings insiders, and 0.00% retail investors. Alan A. Ades is the largest individual Organogenesis Holdings shareholder, owning 128.63M shares representing 97.03% of the company. Alan A. Ades's Organogenesis Holdings shares are currently valued at $317.72M.

If you're new to stock investing, here's how to buy Organogenesis Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.